Background: Although the metabolic syndrome is associated with incident cardiovascular disease, low-density lipoprotein (LDL) cholesterol is a well-known risk factor for coronary atherosclerosis. The aim of this study was to clarify the clinical markers for coronary plaque vulnerability in acute coronary syndrome (ACS) patients (men) without the metabolic syndrome. Methods: Consecutive Japanese men with ACS (n = 264) underwent emergent coronary angiography and B-mode carotid ultrasonography. Common carotid intimamedia thickening and vascular dilatation were considered to indicate carotid artery remodeling. Patients were divided into two groups based on the number of complex plaques identified by coronary angiography. Results: Abdominal obesity and low high-density lipoprotein cholesterol levels were frequently observed in overall patients with multiple complex coronary lesions. Although the metabolic syndrome was a significant independent predictor of multiple complex coronary lesions in overall ACS patients, a high LDL cholesterol level was an independent predictor in ACS patients without the metabolic syndrome. Carotid artery remodeling was an independent predictor of multiple complex coronary lesions in both overall patients and patients without the metabolic syndrome. Conclusion: In ACS patients without the metabolic syndrome, high LDL cholesterol levels and carotid artery remodeling are important indicators for assessing the efficacy of aggressive treatments for secondary prevention of ACS.
Introduction
The metabolic syndrome is defined as the clustering of cardiovascular disease risk factors in an individual, including impaired glucose tolerance, hypertension, dyslipidemia, and abdominal obesity [1] [2] [3] . Components of the metabolic syndrome are common and are associated with incident cardiovascular disease and diabetes [4, 5] . In contrast, the presence of multiple complex coronary lesions identified with coronary angiography has been reported to be associated with an increased incidence of recurrent acute coronary syndrome (ACS) [6, 7] . Goldstein et al. [8] reported that the presence of multiple complex plaques was a strong predictor of adverse cardiovascular events at 1 year. Our previous study [9] showed that the metabolic syndrome is a useful independent predictor of multiple complex coronary lesions in Japanese men with ACS. We demonstrated that abdominal obesity and low levels of high-density lipoprotein (HDL) cholesterol, but not high levels of low-density lipoprotein (LDL) cholesterol, seemed to be the key factors in predicting a greater risk of complex coronary lesions.
It is well established that a low level of HDL cholesterol is a strong predictor of increased cardiovascular disease risk [10] [11] [12] . According to the subanalysis of Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study [13] , plasma HDL cholesterol, but not LDL cholesterol, measured in the initial stage of ACS predicts the risk of recurrent cardiovascular events. However, another study demonstrated a progressive reduction in the benefit of intensive lipid-lowering therapy with statins in ACS patients, as the baseline LDL cholesterol decreased [14] .
Carotid intima-media thickness (IMT) measured by high-resolution B-mode ultrasonography has been proposed as a clinically useful marker for the development of atherosclerosis and its response to therapy [15, 16] . Previously, we showed that multiple complex coronary plaques in ACS are associated with carotid remodeling [17] .
Although the metabolic syndrome is an important predictor of risk stratification of recurrent acute coronary events in men with ACS [9] , LDL cholesterol is a well-known risk factor for coronary atherosclerosis [18] . Important markers for ACS in patients without the metabolic syndrome remain unclear. The aim of this study was to identify the clinical markers for coronary plaque vulnerability in Japanese men with ACS without the metabolic syndrome.
Methods

Study population
This study included 264 consecutive male patients with ACS who were admitted to the Coronary Care Unit of Hiroshima City Asa Hospital. The patients had ischemic chest discomfort with ST-segment elevation or depression of >0.5 mm or T-wave inversion in two or more leads. Among these patients, 234 had acute myocardial infarction diagnosed on the basis of elevated serum levels of creatine kinase (more than twice the upper limit for healthy humans) and creatine kinase-MB fraction (>10% of the total creatine kinase). Thirty patients did not show elevated levels of creatine kinase-MB fraction, and these patients were classified as having unstable angina. All the patients underwent angiography to document the responsible coronary lesions within 24 h after the onset of chest pain. Patients with a history of myocardial infarction, coronary artery bypass grafting, or carotid surgery were excluded. Informed consent was obtained from all patients after providing an explanation of the study.
Patients were divided into two groups based on the number of complex plaques identified by coronary angiography. Metabolic abnormalities were determined using the Japanese criteria for the metabolic syndrome [19] . Patients with the metabolic syndrome had to satisfy the following criteria: abdominal obesity (waist circumference ≥85 cm) as an essential factor combined with 2 or more of the following factors: fasting triglyceride level ≥150 mg/dl and/or HDL cholesterol level <40 mg/dl; high blood pressure (systolic blood pressure ≥130 mmHg, diastolic blood pressure ≥85 mmHg) or use of antihypertensive drug therapy; or fasting glucose level ≥110 mg/dl. Blood samples were analyzed at a hemodynamically steady state 1 week after the onset of ACS.
Diabetes was defined as the presence of any of the following factors: fasting serum glucose level ≥126 mg/dl, fasting glucose level ≥200 mg/dl, self-reported use of medications for diabetes, and self-reported previous physician's diagnosis. LDL cholesterol levels were calculated with the Friedewald formula [20] . High LDL cholesterolemia was defined as a serum LDL cholesterol level of >140 mg/dl.
Coronary angiography
Coronary angiography was performed with the standard Judkins technique and the results were analyzed as previously described, with substantial lesions (which narrowed the vessel diameter by >50%) being measured quantitatively [21] . Complex coronary plaques were identified according to the following criteria [6, 22, 23] : an intraluminal filling defect consistent with a thrombus, defined as an abrupt vessel obstruction with persistence of contrast or an intraluminal filling defect in a patent vessel within or adjacent to a stenotic region with surrounding homogeneous opacification by contrast; plaque ulceration, defined as the presence of contrast and a hazy contour beyond the vessel lumen; plaque irregularity, defined as irregular margins or overhanging edges; and impaired flow. Lesions were considered complex if there was >50% luminal narrowing and they showed two or more of the above mentioned morphologic features, whereas lesions characteristic of chronic total occlusion or >50% luminal narrowing without or with one of these morphologic features was considered simple.
The location of the responsible lesion was determined by correlating the presence of a complex lesion with electrocardiographic and wall motion abnormalities. In each patient, the coronary vasculature was reviewed to identify anatomically remote complex lesions. An anatomically remote lesion was defined as a lesion in an artery different from that containing the responsible lesion, in a different branch of the same artery or in the same branch, but at least 5 cm from the responsible lesion with an intervening disease-free segment. The angiograms were analyzed by two independent angiographers (K.D. and S.S.). The results were compared and a final decision was made by consensus in case of a disagreement.
Ultrasound evaluation
High-resolution B-mode ultrasonography was performed within 1 week of coronary angiography in all patients by a single trained sonographer using an 11.3-MHz linear array ultrasound imaging system (SONOS 5500, Philips Medical Systems, Andover, MA, USA or SSD-2000, Aloka Co. Ltd., Tokyo, Japan). The left and right carotid arteries were scanned with the beam focused on the near and far walls of the distal 2 cm of the common carotid artery proximal to its bifurcation. Both longitudinal and transverse images were obtained to study the plaques. When an optimal longitudinal image was obtained, it was frozen in end-diastole.
The carotid IMT was measured as the distance from the leading edge of the first echogenic line to that of the second echogenic line. The first line represented the luminal-intimal interface, and the second line represented the collagen-containing upper layer of the tunica adventitia. The distance from the first line of the near wall to that of the far wall was defined as the luminal diameter, and the distance from the second line of the near wall to that of the far wall was defined as the interadventitial diameter. Using longitudinal images, the maximum and minimum IMT values of the far wall, their average, and the maximum luminal and interadventitial diameters were determined by the same operator (M.K.), who was blinded to the results of coronary angiography. All measurements were made using electronic calipers. Hyperechoic segments of the carotid wall were identified as calcified atherosclerotic segments. On the basis of our previous study, carotid artery remodeling was defined by the morphology of the common carotid artery, i.e., a mean value of maximum and minimum carotid IMT >1.1 mm and an interadventitial diameter >8.0 mm [17] . Carotid plaques were defined as a distinct area with an IMT 50% thicker than the neighboring sites by visual assessment. Calcification was indicated as any hyperechoic region.
Statistical analysis
The results are presented as the mean ± S.D. Univariate analysis was performed using Student's t test. Categorical data were compared against a chi-squared distribution. The optimal cut-off values for the ratio of LDL to HDL cholesterol for multiple complex coronary lesions were determined from receiver-operator characteristic (ROC) curve analysis. Clinical and carotid ultrasonographic variables were entered into a multivariate logistic regression model of multiple complex coronary lesions to test for their independent effects. Independent clinical variables included older age (>65 years), myocardial infarction, hypertension, diabetes mellitus, high LDL cholesterol level (>140 mg/dl), current smoking, ischemia family history (only including coronary artery disease), and the metabolic syndrome. Carotid ultrasonographic variables included carotid plaque, carotid calcification, and carotid artery remodeling. Odds ratios and 95% confidence intervals were calculated to assess the predictive value. P < 0.05 was considered statistically significant.
Results
Clinical characteristics and carotid artery morphology in overall ACS patients
The clinical characteristics of patients with single and multiple complex coronary lesions are shown in Table 1 . Levels of LDL cholesterol were similar between the two groups. The metabolic syndrome was identified in 91 patients (34%). As in our previous study, abdominal obesity and low levels of HDL cholesterol were the characteristics of the metabolic syndrome that were most frequently observed in patients with multiple complex coronary lesions. B-mode ultrasonographic features of the common carotid artery are shown in Table 2 . The carotid IMT was significantly greater in ACS patients with multiple complex coronary lesions than in patients with solitary lesions. Furthermore, patients with multiple complex lesions had a significantly greater carotid interadventitial diameter and the ratio of interadventitial diameter to luminal diameter than did those with solitary complex lesions. The frequency of carotid plaques was also higher in the group with multiple complex lesions.
Clinical characteristics and carotid artery morphology in ACS patients without the metabolic syndrome
The clinical characteristics of patients without the metabolic syndrome are shown in Table 3 . Although the prevalence of abdominal obesity and low levels of HDL cholesterol was significantly higher in overall patients with multiple complex coronary lesions, it was similar between the two groups in patients without the metabolic syndrome. In contrast, in patients without the metabolic syndrome, the levels of LDL cholesterol were significantly higher in the group with multiple complex coronary lesions.
The carotid IMT and the ratio of interadventitial diameter to luminal diameter were significantly greater in patients with multiple complex coronary lesions than in those with solitary lesions (Table 4 ). The frequency of carotid plaques was also higher in the group with multiple complex coronary lesions.
Optimal ratios of LDL to HDL cholesterol for predicting multiple complex coronary lesions
Patients with multiple complex lesions had a significantly greater ratio of LDL to HDL cholesterol than did those with solitary complex lesions (Tables 1 and  3 ). The ROC curve analysis indicated that the optimal ratio of LDL to HDL cholesterol for predicting the presence of multiple complex coronary lesions was 3.18, with a sensitivity of 61% and a specificity of 59% (area under curve: 0.60; P < 0.006) in overall patients with ACS. In patients without the metabolic syndrome, the optimal ratio of LDL to HDL cholesterol for predicting the presence of multiple complex coronary lesions was also 3.18 with a sensitivity of 55% and a specificity of 68% (area under curve: 0.63; P < 0.003).
Independent predictors of multiple complex coronary lesions
The significant independent predictors of the presence of multiple complex coronary lesions in overall ACS patients were the metabolic syndrome and carotid artery remodeling (Table 5 ). In ACS patients without the metabolic syndrome, the significant independent predictors of multiple complex coro- Values are mean ± S.D. or number (%). IAD, interadventitial diameter; IMTmax, maximal intima-media thickness; IMTmean, mean intima-media thickness; IMTmin, minimal intima-media thickness; LD, luminal diameter. nary lesions were high levels of LDL cholesterol and carotid artery remodeling (Table 5) .
Discussion
In the present study, we found that high levels of LDL cholesterol and carotid artery remodeling were independent predictors of multiple complex coronary lesions in male ACS patients without the metabolic syndrome. The presence of multiple complex coronary lesions identified by coronary angiography has been reported to be associated with an increased incidence of recurrent ACS [6, 7] . Goldstein et al. [8] reported that the presence of multiple complex plaques was the strongest predictor of an adverse outcome, especially in those with high C-reactive protein levels. Our study suggests that a high LDL cholesterol level and carotid artery remodeling might be useful predictors of secondary cardiovascular events in Japanese men with ACS who do not have the metabolic syndrome.
Our previous study showed that the metabolic syndrome and carotid artery remodeling were more frequently observed in male ACS patients with multiple complex coronary lesions. We observed that the incidence of abdominal obesity and low levels of HDL cholesterol, which are characteristics of the metabolic syndrome, were significantly greater in patients with multiple complex coronary lesions. These results support the findings of the subanalysis of the MIRACL study and suggest that the mechanism responsible for acute vascular events in patients with the metabolic syndrome might be related to the underlying vascular remodeling. However, it is worth noting that the LDL cholesterol level is still a very important risk factor for plaque vulnerability in ACS patients with normal HDL cholesterol levels, although low levels of HDL cholesterol is a strong predictor of increased cardiovascular disease risk [10] [11] [12] 24 ]. Since the LDL cholesterol level was calculated with the Friedewald formula in this study, it is likely that the LDL levels were underestimated in patients with the metabolic syndrome. However, the etiology of ACS might be different between patients with and without the metabolic syndrome.
The findings of our previous and present studies suggest the usefulness of the LDL to HDL cholesterol ratio for the secondary prevention of an acute coronary event. There is evidence that the ratio of LDL to HDL cholesterol is a valuable and standard tool for evaluating cardiovascular disease risk in all populations [25] . However, an optimal cut-off value has not been clarified. Since our results suggest that the optimal cut-off value for predicting multiple complex coronary lesions is >3.0, this value might be useful for the secondary prevention of ACS. Additional studies are needed to determine the optimal cut-off ratio of LDL to HDL cholesterol.
We have demonstrated that multiple complex coronary plaques in patients with ACS are associated with carotid remodeling, which is defined by the morphology of common carotid artery, i.e., a mean value of maximum and minimum carotid IMT >1.1 mm and an interadventitial diameter >8.0 mm [17] . Carotid remodeling remains an important predictor of coronary plaque vulnerability in patients without the metabolic syndrome and may be appropriate for evaluating systemic vascular remodeling. It is possible that carotid artery remodeling is also a useful indicator for assessing the efficacy of treatments for the secondary prevention of cardiovascular events in ACS patients. Additional investigations may provide useful information for the management of patients with evidence of carotid artery remodeling.
Study limitations
The lipid profile of the patient might change due to the hyperadrenergic state early after ST-elevation in myocardial infarction. These alterations in lipid and lipoprotein levels generally stabilize by 2 months after an acute event [26] . However, a recent study showed that the mean serum LDL cholesterol levels and other lipid variables vary relatively little over the early days after admission for ACS [27] . Therefore, the lipid levels of the patients in the present study might not vary widely from their normal values.
The Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) study group demonstrated that rosuvastatin significantly reduced the incidence of major cardiovascular events in apparently healthy people without hyperlipidemia but with elevated highsensitivity C-reactive protein levels [28] . Goldstein et al. [8] reported that the presence of multiple complex plaques was the strongest predictor of adverse cardiovascular events, especially in those who had high C-reactive protein levels. We could not show C-reactive protein and other emerging blood biomarkers proposed to optimize risk stratification of vulnerable patients [29] . However, C-reactive protein was not a reliable marker of coronary morphologic changes in our study because it was measured just after the onset of ACS. The measurement of high-sensitivity C-reactive protein during the chronic stage of ACS will be useful for clarifying its relationship with coronary artery morphology.
Conclusions
Japanese men with ACS who do not have the metabolic syndrome are more susceptible to multiple complex coronary lesions if they have high levels of serum LDL cholesterol, which suggests that they are vulnerable to coronary plaque formation. Furthermore, carotid artery remodeling is a useful independent predictor of multiple complex coronary lesions. High levels of LDL cholesterol and carotid artery remodeling as well as abdominal obesity and low levels of HDL cholesterol--characteristic factors of the metabolic syndrome--might be important indicators for assessing the efficacy of aggressive treatments for the secondary prevention of acute coronary events.
